Patents by Inventor Rodney J. Ketner

Rodney J. Ketner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8703196
    Abstract: A pharmaceutical composition comprises a dispersion comprising a low-solubility drug and a matrix combined with a concentration-enhancing polymer. At least a major portion of the drug is amorphous in the dispersion. The compositions improve the stability of the drug in the dispersion, and/or the concentration of drug in a use environment.
    Type: Grant
    Filed: July 31, 2012
    Date of Patent: April 22, 2014
    Assignee: Bend Research, Inc.
    Inventors: Walter C. Babcock, William J. Curatolo, Dwayne T. Friesen, Rodney J. Ketner, Julian B. Lo, James A. S. Nightingale, Ravi M. Shanker, James B. West
  • Publication number: 20120295988
    Abstract: A pharmaceutical composition comprises a dispersion comprising a low-solubility drug and a matrix combined with a concentration-enhancing polymer. At least a major portion of the drug is amorphous in the dispersion. The compositions improve the stability of the drug in the dispersion, and/or the concentration of drug in a use environment.
    Type: Application
    Filed: July 31, 2012
    Publication date: November 22, 2012
    Inventors: Walter C. Babcock, William J. Curatolo, Dwayne T. Friesen, Rodney J. Ketner, Julian B. Lo, James A. S. Nightingale, Ravi M. Shanker, James B. West
  • Patent number: 8236328
    Abstract: A pharmaceutical composition comprises a dispersion comprising a low-solubility drug and a matrix combined with a concentration-enhancing polymer. At least a major portion of the drug is amorphous in the dispersion. The compositions improve the stability of the drug in the dispersion, and/or the concentration of drug in a use environment.
    Type: Grant
    Filed: July 8, 2008
    Date of Patent: August 7, 2012
    Assignee: Bend Research, Inc.
    Inventors: Walter C. Babcock, William J. Curatolo, Dwayne T. Friesen, Rodney J. Ketner, Julian B. Lo, James A. S. Nightingale, Ravi M. Shanker, James B. West
  • Patent number: 8173142
    Abstract: Pharmaceutical compositions comprised of low-solubility and/or acid-sensitive drugs and neutralized acidic polymers are disclosed.
    Type: Grant
    Filed: June 5, 2006
    Date of Patent: May 8, 2012
    Assignee: Bend Research, Inc.
    Inventors: Marshall Crew, Dwayne T. Friesen, Rodney J. Ketner, Ravi M. Shanker, James B. West
  • Patent number: 8147872
    Abstract: Pharmaceutical compositions comprised of low-solubility and/or acid-sensitive drugs and neutralized acidic polymers are disclosed.
    Type: Grant
    Filed: August 26, 2005
    Date of Patent: April 3, 2012
    Assignee: Bend Reseach, Inc.
    Inventors: Marshall Crew, Dwayne T. Friesen, Rodney J. Ketner, Ravi M. Shanker, James B. West
  • Publication number: 20090011024
    Abstract: A pharmaceutical composition comprises a dispersion comprising a low-solubility drug and a matrix combined with a concentration-enhancing polymer. At least a major portion of the drug is amorphous in the dispersion. The compositions improve the stability of the drug in the dispersion, and/or the concentration of drug in a use environment.
    Type: Application
    Filed: July 8, 2008
    Publication date: January 8, 2009
    Inventors: Walter C. Babcock, William J. Curatolo, Dwayne T. Friesen, Rodney J. Ketner, Julian B. Lo, James A.S. Nightingale, Ravi M. Shanker, James B. West
  • Publication number: 20040185102
    Abstract: A dosage form comprises (1) a solid amorphous dispersion comprising a cholesteryl ester transfer protein inhibitor and a neutral or neutralized acidic polymer and (2) an HMG-CoA reductase inhibitor. The dosage form provides improved chemical stability of the HMG-CoA reductase inhibitor.
    Type: Application
    Filed: December 18, 2003
    Publication date: September 23, 2004
    Applicant: Pfizer Inc
    Inventors: Dwayne T. Friesen, David K. Lyon, Douglas A. Lorenz, Rodney J. Ketner, Bruno C. Hancock, Timothy J. McDermott, Ravi M. Shanker
  • Publication number: 20030104063
    Abstract: A pharmaceutical composition comprises a dispersion comprising a low-solubility drug and a matrix combined with a concentration-enhancing polymer. At least a major portion of the drug is amorphous in the dispersion. The compositions improve the stability of the drug in the dispersion, and/or the concentration of drug in a use environment.
    Type: Application
    Filed: June 19, 2002
    Publication date: June 5, 2003
    Inventors: Walter C. Babcock, William J. Curatolo, Dwayne T. Friesen, Rodney J. Ketner, Julian B. Lo, James A. S. Nightingale, Ravi M. Shanker, James B. West
  • Publication number: 20030091643
    Abstract: In one aspect, pharmaceutical compositions comprising dispersions of an acid-sensitive drug and a neutral dispersion polymer are disclosed. The acid-sensitive drug has improved chemical stability relative to dispersions of the drug and acidic polymers. In another aspect, pharmaceutical compositions of low-solubility drugs and amphiphilic, hydroxy-functional vinyl copolymers are disclosed.
    Type: Application
    Filed: June 18, 2002
    Publication date: May 15, 2003
    Inventors: Dwayne T. Friesen, Michael J. Gumkowski, Rodney J. Ketner, Douglas A. Lorenz, James A. S. Nightingale, Ravi M. Shanker, James B. West
  • Publication number: 20030054038
    Abstract: Pharmaceutical compositions comprised of low-solubility and/or acid-sensitive drugs and neutralized acidic polymers are disclosed.
    Type: Application
    Filed: June 17, 2002
    Publication date: March 20, 2003
    Inventors: Marshall D. Crew, Dwayne T. Friesen, Rodney J. Ketner, Ravi M. Shanker, James B. West